Literature DB >> 22273139

Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali.

Brett MacLean1, Rosanna F Hess, Edward Bonvillain, Joseph Kamate, Daoda Dao, Amy Cosimano, Shannon Hoy.   

Abstract

OBJECTIVE: To establish the rate of seroprevalence of the hepatitis B surface antigen in pregnant women in south-eastern Mali, and to decrease mother-to-child transmission.
METHODS: In a descriptive cross-sectional comparison study, 3 659 pregnant women attending a non-governmental hospital in Koutiala, Mali, during 2008 and 2009 were screened for the hepatitis B surface antigen during antenatal clinic attendance or when admitted for delivery. A chart review compared the hepatitis B virus (HBV)-positive women to HBV-negative women used as controls to identify potential risk factors for HBsAg positivity. The variables compared were age, parity, type of genital excision, birthweight of baby and HIV status.
RESULTS: A total of 293 (8.0%) pregnant women tested positive for HBsAg. Their average age was 27.6 years, average parity of 2.8 births, 90% had Type 2 genital excision, 21% had low birthweight infants, and 14 (0.4%) women also tested positive for HIV. Infants born to HbsAg-positive women were immunised with the hepatitis B vaccine in the delivery room. Two hundred and eighty-four HBV-negative women were compared with the HBV-positive women. None of the differences of means or relationships was statistically insignificant.
CONCLUSION: In view of the high endemicity and lack of easily identifiable risk factors, free maternal HBV screening should be provided to all women in Mali, and the infants born to HBsAg-positive women should be immunised within 12 hours of birth.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22273139

Source DB:  PubMed          Journal:  S Afr Med J


  25 in total

Review 1.  HIV/HBV coinfection in children and antiviral therapy.

Authors:  Sara A Healy; Sonia Gupta; Ann J Melvin
Journal:  Expert Rev Anti Infect Ther       Date:  2013-03       Impact factor: 5.091

2.  Molecular characteristics of Hepatitis B and chronic liver disease in a cohort of HB carriers from Bamako, Mali.

Authors:  Fatou Traoré; Emmanuelle Gormally; Stéphanie Villar; Marlin D Friesen; John D Groopman; Guy Vernet; Souleymane Diallo; Pierre Hainaut; Moussa Y Maiga
Journal:  BMC Infect Dis       Date:  2015-04-11       Impact factor: 3.090

3.  Seroprevalence and Predictors of Hepatitis B Virus Infection among Pregnant Women Attending Routine Antenatal Care in Arba Minch Hospital, South Ethiopia.

Authors:  Tsegaye Yohanes; Zerihun Zerdo; Nega Chufamo
Journal:  Hepat Res Treat       Date:  2016-01-24

Review 4.  The status of hepatitis B control in the African region.

Authors:  Lucy Breakwell; Carol Tevi-Benissan; Lana Childs; Richard Mihigo; Rania Tohme
Journal:  Pan Afr Med J       Date:  2017-06-22

5.  Sero-Prevalence and Associated Factors of Hepatitis B Virus Among Pregnant Women at North West Ethiopia: An Institution-Based Cross-Sectional Study.

Authors:  Gebreselassie Demeke; Getachew Mengistu Ayalneh; Abtie Abebaw Shiferaw; Milkiyas Toru; Tebelay Dilnessa
Journal:  Int J Gen Med       Date:  2021-06-24

6.  Sero-prevalence and risk factors of hepatitis B virus and human immunodeficiency virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross sectional study.

Authors:  Yohannes Zenebe; Wondemagegn Mulu; Mulat Yimer; Bayeh Abera
Journal:  BMC Infect Dis       Date:  2014-03-01       Impact factor: 3.090

7.  Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia: a cross sectional study.

Authors:  Dessie Tegegne; Kassu Desta; Belete Tegbaru; Tesfaye Tilahun
Journal:  BMC Res Notes       Date:  2014-04-15

8.  Hepatitis B and human immunodeficiency virus co-infection among pregnant women in resource-limited high endemic setting, Addis Ababa, Ethiopia: implications for prevention and control measures.

Authors:  Zelalem Desalegn; Liya Wassie; Habtamu Bedimo Beyene; Adane Mihret; Yehenew A Ebstie
Journal:  Eur J Med Res       Date:  2016-04-14       Impact factor: 2.175

9.  Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study.

Authors:  Yeshi Metaferia; Walelign Dessie; Ibrahim Ali; Anteneh Amsalu
Journal:  Epidemiol Health       Date:  2016-06-19

10.  Hepatitis B surface antigen and associated factors among mothers who had antenatal care contact in Attat Hospital, southern Ethiopia.

Authors:  Yohannes Fikadu Geda; Hailu Desse; Molalegn Mesele Gesesse; Tamirat Melis Berhe
Journal:  SAGE Open Med       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.